Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement

Cardiac Science Expands into Vital Signs Market with Exclusive OMRON
Healthcare Agreement
Cardiac Science to distribute OMRON products in the US and Canada

BOTHELL, Wash., Oct. 20 /PRNewswire-FirstCall/ -- Cardiac Science Corporation
(Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and
diagnostic cardiac monitoring devices, entered into an exclusive agreement
with OMRON Healthcare distribute Omron's vital signs and spot check monitors
under the Cardiac Science brand in the United States and Canada. OMRON
Healthcare is a subsidiary of OMRON Corporation, the $7-billion global leader
in the sensing and control market and the global leader in blood pressure
monitoring with sales of more than 100 million blood pressure units worldwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO )

"This deal leverages our industry-leading distribution capabilities. OMRON is
an outstanding company with an excellent reputation for quality," said Dave
Marver, Cardiac Science's president and chief executive officer. "They are an
ideal partner to help us enter the North American vital signs market."

"When we looked to expand our U.S. based sales into the diagnostic market for
healthcare professionals," said Bob Kondraske, chief operating officer for
OMRON Healthcare, Inc., "we needed a partner with deep industry knowledge and
solid distribution. Cardiac Science is a leader in ECG, Holter, cardiac
stress, and automated external defibrillation sales into the physician office.
In addition, they have a strong direct sales force in the hospital market.
They've demonstrated their commitment and skill selling into both marketplaces
- which is exactly what we needed."

Vital signs monitors sold under the exclusive agreement are available for sale
next Monday under the Cardiac Science name, while clearly featuring the
accuracy of the OMRON technology. "This allows customers to recognize the
strengths of both brands, and know they're purchasing from a partnership
comprising two world leaders," Kondraske added.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced
diagnostic and therapeutic cardiology devices and systems, including automated
external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac
stress treadmill and systems, Holter monitoring systems, hospital
defibrillators, cardiac rehabilitation telemetry systems, vital signs
monitors, and cardiology data management systems (informatics) that connect
with hospital information (HIS), electronic medical record (EMR), and other
information systems. The company sells a variety of related products and
consumables and provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses that
established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton®
brands, is headquartered in Bothell, Washington. With customers in more than
100 countries worldwide, the company has operations in North America, Europe,
and Asia. For information, call 425.402.2000 or visit
http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac
monitoring, find us on the Cardiac Science blog at
http://www.cardiacscience.com/blog, Twitter at
http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and
YouTube at http://budurl.com/CSonYT.

About OMRON Healthcare

Omron Healthcare, Inc., located in Bannockburn, IL, is the North and South
American sales and marketing office of Omron Healthcare Group, a leading
manufacturer and distributor of blood pressure monitors for home use. With
more than 100 million monitors sold worldwide to date, Omron Healthcare Group
was the first to introduce manual and digital blood pressure monitors into the
home healthcare market. Omron Healthcare offers innovative products and
medical devices for use in sites ranging from hospitals to the home in the
blood pressure monitoring, fitness diagnostics, thermometry, and respiratory
categories. Omron Healthcare markets clinically proven products that provide
accurate health information to consumers and physicians and support positive
lifestyle changes and health improvement. For information, call 847.247.5637
or visit www.omronhealthcare.com or www.omronwebstore.com.

Forward Looking Statements

This press release contains forward-looking statements. The words "believe,"
"expect," "intend," "anticipate," variations of such words, and similar
expressions identify forward-looking statements, but their absence does not
mean that the statement is not forward-looking. Forward looking statements in
this press release include, but are not limited to, those relating to Cardiac
Science Corporation's expectations regarding the impact of the agreement with
OMRON Healthcare on Cardiac Science's growth and regarding future distribution
partnerships. These are forward-looking statements for purposes of the safe
harbor provisions under the Private Securities Litigation Reform Act of 1995.
Actual results may vary significantly from the results expressed or implied in
such statements. Factors that could cause or contribute to such varying
results and other risks are more fully described in Cardiac Science
Corporation's Annual Report on Form 10-K for the year ended December 31, 2008
and Quarterly Report on Form 10-Q for the quarter ended June 30, 2009. Cardiac
Science Corporation undertakes no duty or obligation to update the information
provided herein.

For more information,
-------------------------------------------------------------------------
Cardiac Science Contact: Investor Contact: Media Contact:
------------------------ ----------------- --------------------
Mike Matysik Matt Clawson Christopher Gale
Cardiac Science Corporation Allen & Caron EVC Group Inc.
Senior Vice President and CFO 949.474.4300 646.201.5431
425.402.2009 matt@allencaron.com 203.570.4681
cgale@evcgroup.com
-------------------------------------------------------------------------
OMRON Healthcare Contact:
-------------------------
Johnna Purcell
OMRON Healthcare
847.247.5637

CSCX-G

SOURCE Cardiac Science Corporation

Mike Matysik, Senior Vice President and CFO of Cardiac Science Corporation,
+1-425-402-2009; Investors: Matt Clawson of Allen & Caron, +1-949-474-4300,
matt@allencaron.com; Media: Christopher Gale of EVC Group Inc.,
+1-646-201-5431, +1-203-570-4681, cgale@evcgroup.com, all for Cardiac Science
Corporation; or Johnna Purcell of OMRON Healthcare, +1-847-247-5637